Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at In

LAVAL, QC / ACCESSWIRE / June 14, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, recently presented at two global healthcare conferences. Bausch Health's gastroenterology (GI) business,...

Related Keywords

Washington ,United States ,Italy ,New Jersey ,Milan ,Lombardia ,Steven Hanauer ,Pabout Amiselimod ,Kevin Wiggins ,Clifford Joseph Barborka ,Garen Sarafian ,Twitter ,International Liver Congress ,Bausch Health ,University Of Alberta ,Salix Pharmaceuticals ,Pharmacological Research ,Bausch Health Companies Inc ,Linkedin ,Professor Of Medicine At Northwestern University ,Bausch Health Companies ,Digestive Disease Week ,Annual Meeting ,European Association ,Modified Mayo Score ,Health Companies ,